Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Conditions
Interventions
VC005 tablets
Tofacitinib Citrate Tablets
+1 more
Locations
1
China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Start Date
April 26, 2023
Primary Completion Date
May 11, 2024
Completion Date
May 11, 2024
Last Updated
July 29, 2024
Lead Sponsor
Jiangsu vcare pharmaceutical technology co., LTD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions